Companies: 10,795·Total market cap: $144.5T

VectivBio Holding AG

VectivBio Holding AG

VECTNASDAQHealthcare

$16.87

+$0.02(+0.12%)

Market Cap$1.1B

P/E Ratio—

52W High$16.98

52W Low$4.25

Avg Volume1.3M

Open$16.80

Beta0.10

Net Income Financials Revenue

VectivBio Holding AG (VECT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

VECT · net income · updated Jun 9, 2026

Core profitability metrics

VECT · net income · margin · TTM · CAGR

Net income was −$93.7M for FY2022 (fiscal year ending 2022-12-31), down 7.7% year-over-year. Net profit margin was -342.8%.

FY2022 Net Income−$93.7M▼ -7.7% YoY

Trailing 12M (TTM)−$180.7Mtrailing 4 quarters sum

Net Profit Margin-342.8%−$93.7M ÷ $27.3M

YoY Change-7.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · VECT net income history · VECT profit margin

Annual net income data

VECT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$93.7M▼ 7.7%-342.8%$27.3M

FY2021Loss−$87.0M▼ 43.8%—$0

FY2020Loss−$60.5M▼ 157.1%—$0

FY2019Loss−$23.5M——$0

Net income vs peers (Healthcare)

VECT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

VectivBio Holding AGYOU

VECT

−$93.7M-7.7%-342.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

VectivBio Holding AG (VECT) reported net income of −$93.7M for FY2022 (fiscal year ending 2022-12-31), down 7.7% year-over-year. The net profit margin was -342.8% — meaning the company kept $-3.43 of every dollar of revenue as profit.

VectivBio Holding AG has not yet achieved annual profitability based on available data (4 fiscal years). The company has reported net losses across all available periods.

VectivBio Holding AG's net profit margin was -342.8% for FY2022, based on the latest annual results.

Investors sometimes search for "VectivBio Holding AG net worth" — the company's market capitalization is a separate figure from VECT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

VECT net income · 4 questions

VectivBio Holding AG is not currently profitable on an annual basis. The company reported a net loss of $93.7M for FY2022.

is VECT profitabledoes VECT make a profitVECT profitabilityVECT profitable company

▸ Source: FMP /income-statement · GAAP · VectivBio Holding AG · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026